417 related articles for article (PubMed ID: 19493611)
21. Morpholino-Mediated Exons 28-29 Skipping of Dysferlin and Characterization of Multiexon-skipped Dysferlin using RT-PCR, Immunoblotting, and Membrane Wounding Assay.
Anwar S; Yokota T
Methods Mol Biol; 2023; 2587():183-196. PubMed ID: 36401031
[TBL] [Abstract][Full Text] [Related]
22. [Distal myopathy due to mutations of GNE gene: clinical spectrum and diagnosis].
Béhin A; Dubourg O; Laforêt P; Pêcheux C; Bernard R; Lévy N; Eymard B
Rev Neurol (Paris); 2008 May; 164(5):434-43. PubMed ID: 18555875
[TBL] [Abstract][Full Text] [Related]
23. Dysferlinopathy in Chile: evidence of two novel mutations in the first reported cases.
Bevilacqua JA; Krahn M; Pedraza L; Gejman R; Gonzalez S; Lévy N
Genet Test Mol Biomarkers; 2009 Feb; 13(1):105-8. PubMed ID: 19309282
[TBL] [Abstract][Full Text] [Related]
24. Miyoshi Muscular Dystrophy Type 1 with Mutated
Park J; Moon YJ; Kim DS
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672942
[TBL] [Abstract][Full Text] [Related]
25. Private dysferlin exon skipping mutation (c.5492G>A) with a founder effect reveals further alternative splicing involving exons 49-51.
Santos R; Oliveira J; Vieira E; Coelho T; Carneiro AL; Evangelista T; Dias C; Fortuna A; Geraldo A; Negrão L; Guimarães A; Bronze-da-Rocha E
J Hum Genet; 2010 Aug; 55(8):546-9. PubMed ID: 20535123
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic features and genetic findings in 2 chinese families with Miyoshi distal myopathy.
Ro LS; Lee-Chen GJ; Lin TC; Wu YR; Chen CM; Lin CY; Chen ST
Arch Neurol; 2004 Oct; 61(10):1594-9. PubMed ID: 15477515
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneous characteristics of Korean patients with dysferlinopathy.
Park HJ; Hong JM; Suh GI; Shin HY; Kim SM; Sunwoo IN; Suh BC; Choi YC
J Korean Med Sci; 2012 Apr; 27(4):423-9. PubMed ID: 22468107
[TBL] [Abstract][Full Text] [Related]
29. Nemaline myopathy caused by mutations in the nebulin gene may present as a distal myopathy.
Lehtokari VL; Pelin K; Herczegfalvi A; Karcagi V; Pouget J; Franques J; Pellissier JF; Figarella-Branger D; von der Hagen M; Huebner A; Schoser B; Lochmüller H; Wallgren-Pettersson C
Neuromuscul Disord; 2011 Aug; 21(8):556-62. PubMed ID: 21724397
[TBL] [Abstract][Full Text] [Related]
30. Late-onset distal muscular dystrophy affecting the posterior calves.
Katz JS; Rando TA; Barohn RJ; Saperstein DS; Jackson CE; Wicklund M; Amato AA
Muscle Nerve; 2003 Oct; 28(4):443-8. PubMed ID: 14506716
[TBL] [Abstract][Full Text] [Related]
31. Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies.
Cagliani R; Magri F; Toscano A; Merlini L; Fortunato F; Lamperti C; Rodolico C; Prelle A; Sironi M; Aguennouz M; Ciscato P; Uncini A; Moggio M; Bresolin N; Comi GP
Hum Mutat; 2005 Sep; 26(3):283. PubMed ID: 16100712
[TBL] [Abstract][Full Text] [Related]
32. A new phenotype of dysferlinopathy with congenital onset.
Paradas C; González-Quereda L; De Luna N; Gallardo E; García-Consuegra I; Gómez H; Cabello A; Illa I; Gallano P
Neuromuscul Disord; 2009 Jan; 19(1):21-5. PubMed ID: 19084402
[TBL] [Abstract][Full Text] [Related]
33. The clinical, myopathological, and molecular characteristics of 26 Chinese patients with dysferlinopathy: a high proportion of misdiagnosis and novel variants.
Wang N; Han X; Hao S; Han J; Zhou X; Sun S; Tang J; Lu Y; Wu H; Ma S; Song X; Ji G
BMC Neurol; 2022 Nov; 22(1):398. PubMed ID: 36319958
[TBL] [Abstract][Full Text] [Related]
34. Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients.
Au CG; Butler TL; Egan JR; Cooper ST; Lo HP; Compton AG; North KN; Winlaw DS
Acta Neuropathol; 2008 Sep; 116(3):235-46. PubMed ID: 18392839
[TBL] [Abstract][Full Text] [Related]
35. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic variability in a Spanish family with a Caveolin-3 mutation.
González-Pérez P; Gallano P; González-Quereda L; Rivas-Infante E; Teijeira S; Navarro C; Bautista-Lorite J
J Neurol Sci; 2009 Jan; 276(1-2):95-8. PubMed ID: 18930476
[TBL] [Abstract][Full Text] [Related]
37. Dysferlin expression in monocytes: a source of mRNA for mutation analysis.
De Luna N; Freixas A; Gallano P; Caselles L; Rojas-García R; Paradas C; Nogales G; Dominguez-Perles R; Gonzalez-Quereda L; Vílchez JJ; Márquez C; Bautista J; Guerrero A; Salazar JA; Pou A; Illa I; Gallardo E
Neuromuscul Disord; 2007 Jan; 17(1):69-76. PubMed ID: 17070050
[TBL] [Abstract][Full Text] [Related]
38. Dysferlinopathy in Tunisia: clinical spectrum, genetic background and prognostic profile.
Belhassen I; Laroussi S; Sakka S; Rekik S; Lahkim L; Dammak M; Authier FJ; Mhiri C
Neuromuscul Disord; 2023 Oct; 33(10):718-727. PubMed ID: 37716854
[TBL] [Abstract][Full Text] [Related]
39. Miyoshi-like distal myopathy with mutations in anoctamin 5 gene.
Bouquet F; Cossée M; Béhin A; Deburgrave N; Romero N; Leturcq F; Eymard B
Rev Neurol (Paris); 2012 Feb; 168(2):135-41. PubMed ID: 22336395
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
